Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
LLY stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Eli Lilly and Company stock logo

Eli Lilly and Company

LLY·NYSE

Last updated as of 2026-02-10 10:34 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

LLY stock price change

On the last trading day, LLY stock closed at 1059.00 USD, with a price change of 0.08% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

LLY key data

Previous close1059.00 USD
Market cap1.00T USD
Volume1.08M
P/E ratio46.13
Dividend yield (TTM)0.57%
Dividend amount1.50 USD
Last ex-dividend dateNov 14, 2025
Last payment dateDec 10, 2025
EPS diluted (TTM)22.96 USD
Net income (FY)10.59B USD
Revenue (FY)45.04B USD
Next report dateFeb 4, 2026
EPS estimate6.950 USD
Revenue estimate17.92B USD
Shares float851.54M
Beta (1Y)0.45
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Eli Lilly and Company overview

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firms products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
David A. Ricks
Headquarters
Indianapolis
Website
lilly.com
Founded
1876
Employees (FY)
47K
Change (1Y)
+4K +9.30%
Revenue / Employee (1Y)
958.36K USD
Net income / Employee (1Y)
225.32K USD

LLY Pulse

Daily updates on LLY stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• LLY Stock Price 24h change: +3.66%. From 1020.84 USD to 1058.18 USD.
• The stock rose significantly due to the announcement of a $2.4 billion acquisition of Orna Therapeutics and a strong 2026 sales forecast driven by surging demand for its obesity treatments, Zepbound and Mounjaro.
• From a technical perspective, the stock is showing a "bullish consolidation": LLY is trading above its 8-day (1039.85), 20-day (1052.95), and 200-day (859.49) moving averages, indicating strong upward momentum. While the RSI (51.12) is neutral, a recent bounce from the $1000 psychological support suggests buying pressure remains robust.
• Eli Lilly announced a deal to acquire Orna Therapeutics for up to $2.4 billion on February 9, 2026, aiming to bolster its pipeline with next-generation circular RNA and CAR-T therapies for autoimmune diseases.
• The company provided a bullish 2026 outlook on February 4, forecasting revenue between $80-$83 billion, which significantly exceeded analyst expectations and highlighted a widening market share lead over rival Novo Nordisk.
• Eli Lilly deepened its partnership with Innovent Biologics on February 9 through a $350 million oncology and immunology pact, further expanding its global footprint and R&D network.
• On February 9, 2026, the FDA signaled it would take stricter enforcement action against non-FDA-approved compounded versions of GLP-1 drugs, a move seen as protective for major manufacturers like Lilly and Novo Nordisk.
• Global pharmaceutical sentiment remains cautious regarding "Trump 2.0" healthcare policies, with ongoing discussions centered on drug pricing reforms, tariffs on imported medical ingredients, and the official debut of "TrumpRx" discount programs.
See more
about 23h ago
• LLY Stock Price 24h change: +3.66%. From 1020.84 USD to 1058.18 USD. Driven by strong Q4 earnings and robust 2026 revenue guidance.
• From a technical perspective, the stock shows a "bullish recovery within an uptrend": the price successfully tested the 50-day moving average (1043.63) and is supported by key SMAs (8-day, 20-day, and 50-day). While the MACD is currently neutral to slightly bearish, the RSI at 53.71 indicates stable momentum without being overbought, suggesting room for further gains if it breaks above recent resistance.
• Eli Lilly reported Q4 revenue of $19.3 billion and projected 2026 sales of $80-83 billion, significantly exceeding analyst expectations due to massive demand for obesity drugs Zepbound and Mounjaro.
• JPMorgan and BMO Capital raised their price targets for LLY to $1,300, citing the company's leading position in the incretin market and the anticipated 2026 launch of oral weight-loss drug orforglipron.
• The Trump Administration officially launched "TrumpRx," a discount drug platform featuring manufacturers like Eli Lilly and Novo Nordisk that agreed to most-favored-nation pricing in exchange for policy incentives.
• The pharmaceutical sector is facing a critical "turning point" in 2026 as companies balance record-breaking GLP-1 drug demand against intensifying U.S. government pressure to lower list prices for Medicare beneficiaries.
• Major pharmaceutical players including Bristol Myers Squibb are accelerating AI adoption, recently partnering with Microsoft for AI-driven lung cancer detection to streamline drug discovery and diagnostic workflows.
See more
about 1D ago

LLY stock price forecast

According to technical indicators for LLY stock, the price is likely to fluctuate within the range of 1127.87–1320.72 USD over the next week. Market analysts predict that the price of LLY stock will likely fluctuate within the range of 1113.94–1322.95 USD over the next months.

Based on 1-year price forecasts from 85 analysts, the highest estimate is 1533.79 USD, while the lowest estimate is 773.97 USD.

For more information, please see the LLY stock price forecast Stock Price Forecast page.

Latest LLY stock news

Why Eli Lilly (LLY) Stock Is Plummeting Today

101 finance2026-02-05 17:18:15

All three major U.S. stock indexes closed lower, with popular tech stocks falling across the board.

格隆汇2026-02-05 22:11:44

Top 20 U.S. Stocks by Trading Volume on February 6: Amazon Expected to Reach $200 Billion in Capital Expenditures This Year

新浪财经2026-02-05 22:23:28

Bitget UEX Daily | Spot Gold & Silver Continue to Drop, Bitcoin Crashes; Amazon’s $200 B Capital Expenditure Raises Concerns; U.S. Job Openings Fall to 2020 Lows — Feb 6, 2026 (English Translation)

Bitget2026-02-06 01:13:12

US equity fund inflows ease as tech selloff weighs

101 finance2026-02-06 10:42:32

Hims & Hers drops 6.5% in early trading following legal threat from Novo Nordisk

新浪财经2026-02-06 15:41:17

Hims & Hers abandons proposal to create imitation of Novo Nordisk's latest Wegovy weight loss medication

101 finance2026-02-07 22:42:33

Hims drops intention to offer compounded GLP-1 capsules following FDA criticism

101 finance2026-02-08 01:24:10

Deutsche Bank raises Eli Lilly's target price to $1,285

格隆汇2026-02-09 12:08:02

Lilly plans to acquire Orna Therapeutics in a deal valued at as much as $2.4 billion

101 finance2026-02-09 12:18:31

Pre-market: Nasdaq futures fall 0.33%, Goldman Sachs says US stock sell-off not over

新浪财经2026-02-09 13:50:36

U.S. stocks open lower, weight loss drug concept stocks generally rise, Novo Nordisk up over 5%

格隆汇2026-02-09 14:35:02

Hims & Hers shares plummet following FDA's announcement of 'firm action' regarding GLP-1 substances

101 finance2026-02-09 15:51:33

Eli Lilly to acquire Orna for $2.4 billion to strengthen its presence in the autoimmune field

格隆汇2026-02-10 01:15:30

What Are the Anticipated Outcomes for Royalty Pharma’s (RPRX) Fourth Quarter Earnings

101 finance2026-02-10 03:21:37

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Eli Lilly and Company?

LLY is currently priced at 1059.00 USD — its price has changed by 0.08% over the past 24 hours. You can track the stock price performance of Eli Lilly and Company more closely on the price chart at the top of this page.

What is the stock ticker of Eli Lilly and Company?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Eli Lilly and Company is traded under the ticker LLY.

What is the stock forecast of LLY?

We've gathered analysts' opinions on Eli Lilly and Company's future price. According to their forecasts, LLY has a maximum estimate of 10590.00 USD and a minimum estimate of 2118.00 USD.

What is the market cap of Eli Lilly and Company?

Eli Lilly and Company has a market capitalization of 1.00T USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
LLY